Paper Title:
Effect of Arthrigia on Adjuvant Arthritis Rats’ IL-12
  Abstract

Rheumatoid Arthritis (RA) is a systemic chronic autoimmune disease. To study the therapeutic mechanism of effects of Skullcap Brightviolet (SB),glucosamine/chondroitin (GC),and the combination of them (named Arthrigia) on RA. With the adjuvant arthritis (AA) rat models, we observed the protective effects of oral SB, GC and Arthrigia in different concentrations on AA in rats. We further examined the immunological mechanism of the combination of them by testing the rats’ secretion of IL-12. The results showed that Arthrigia inhibited the production and secretion of IL-12 factors in some extent, and its effects are more potent the single SB or GC. The present study provides the experimental evidences for Arthrigia for its further development, clinical prevention and treatment of RA.

  Info
Periodical
Edited by
Robert Zhu
Pages
43-47
DOI
10.4028/www.scientific.net/AMM.140.43
Citation
X. Chen, C. Y. Zhang, H. G. Xue, "Effect of Arthrigia on Adjuvant Arthritis Rats’ IL-12", Applied Mechanics and Materials, Vol. 140, pp. 43-47, 2012
Online since
November 2011
Export
Price
$35.00
Share

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: Ke Xin Sun, Yan Li, Chen Zhao, Chun Hui Li, Su Hong Guo, Yi Ju Hou
VI. Medical and Pharmacology, Biotechnology and Agriculture
Abstract:To investigate DcR3 Levels of peripheral blood in rheumatoid arthritis (RA),and analyzes the correlation between the DcR3 Levels of...
1184
Authors: Zhao Wen Liu, Hai Qing Liu, Lin Fu Li, Liang Yu Jiao, Long Huo Wu
Chapter 2: Biomaterials, Medicine, Biotechnologies and Pharmaceutics
Abstract:Osteoarthritis (OA) is a degenerative joint disease that affects millions of people. Currently, there is no effective drug treatment for it....
287